Perrigo Company PLC
PRGO21.190USD
-0.060-0.28%
Fechamento 10/13, 16:00（ET）Cotações atrasadas em 15 min
2.92BValor de mercado
PerdaP/L TTM
Mais detalhes de Perrigo Company PLC Empresa
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Informações de Perrigo Company PLC
Código da empresaPRGO
Nome da EmpresaPerrigo Company PLC
Data de listagemDec 17, 1991
CEOMr. Patrick Lockwood-Taylor
Número de funcionários8379
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 17
EndereçoThe Sharp Building
CidadeDUBLIN
Bolsa de valoresNYSE Consolidated
PaísIreland
Código postalD02 TY74
Telefone3532696738451
Sitehttps://www.perrigo.com/
Código da empresaPRGO
Data de listagemDec 17, 1991
CEOMr. Patrick Lockwood-Taylor
Executivos da empresa Perrigo Company PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+22.91%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+40.91%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+95.21%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+178.57%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
Outro
299.20M
28.33%
Por RegiãoUSD
Nome
Receita
Proporção
United States
610.90M
57.83%
Europe
421.70M
39.92%
All other countries
23.70M
2.24%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
Outro
299.20M
28.33%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
Outro
60.02%
Investidores
Investidores
Proporção
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
Outro
60.02%
Tipos de investidores
Investidores
Proporção
Investment Advisor
61.46%
Investment Advisor/Hedge Fund
33.51%
Hedge Fund
5.68%
Research Firm
1.96%
Pension Fund
1.49%
Sovereign Wealth Fund
1.05%
Bank and Trust
0.64%
Individual Investor
0.45%
Family Office
0.05%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
759
145.63M
105.85%
-23.73M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
2023Q2
837
137.28M
101.45%
-14.92M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Associates, Inc.
14.43M
10.49%
+143.89K
+1.01%
Jun 30, 2025
The Vanguard Group, Inc.
13.96M
10.15%
+58.03K
+0.42%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.76M
8.55%
-46.83K
-0.40%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
7.51M
5.46%
+377.67K
+5.29%
Jun 30, 2025
State Street Global Advisors (US)
7.34M
5.34%
+637.68K
+9.51%
Jun 30, 2025
DePrince, Race & Zollo, Inc.
4.56M
3.32%
-7.61K
-0.17%
Jun 30, 2025
Ion Asset Management Israel Ltd
3.82M
2.77%
+983.73K
+34.71%
Jun 30, 2025
Neuberger Berman, LLC
3.71M
2.7%
-88.92K
-2.34%
Jun 30, 2025
Cooke & Bieler, L.P.
3.30M
2.4%
-241.34K
-6.82%
Jun 30, 2025
Sound Shore Management, Inc.
3.29M
2.39%
+2.50K
+0.08%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
Sound Equity Dividend Income ETF
3.77%
SPDR S&P Pharmaceuticals ETF
2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.08%
Invesco Pharmaceuticals ETF
2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.59%
iShares U.S. Pharmaceuticals ETF
1.52%
Invesco High Yield Equity Dividend Achievers ETF
1.4%
Cultivar ETF
1.3%
Invesco S&P MidCap 400 Pure Value ETF
1.3%
Ver Mais
Sound Equity Dividend Income ETF
Proporção3.77%
SPDR S&P Pharmaceuticals ETF
Proporção2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proporção2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2.08%
Invesco Pharmaceuticals ETF
Proporção2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
Proporção1.59%
iShares U.S. Pharmaceuticals ETF
Proporção1.52%
Invesco High Yield Equity Dividend Achievers ETF
Proporção1.4%
Cultivar ETF
Proporção1.3%
Invesco S&P MidCap 400 Pure Value ETF
Proporção1.3%
Dividendo
Um total de
698.10M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
May 04, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Jun 20, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jun 20, 2023
Jun 01, 2023
Feb 21, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Mar 28, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 28, 2023
Mar 09, 2023
Nov 04, 2022
PRGO.NB Final Cash Dividend of gross USD 0.26 paid on Dec 20, 2022 going ex on Dec 01, 2022
Dec 02, 2022
Dec 20, 2022
Dec 01, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
